PROGNOSTIC RELEVANCE OF SERUM HYALURONAN LEVELS IN PATIENTS WITH BREAST-CANCER

被引：18
|
作者：
PONTING, J
HOWELL, A
PYE, D
KUMAR, S
机构：
[1] CHRISTIE HOSP, DEPT MED ONCOL, CRC DEPT MED, MANCHESTER M28 9BX, ENGLAND
[2] CHRISTIE HOSP, DEPT CLIN RES, MANCHESTER M28 9BX, ENGLAND
来源：
INTERNATIONAL JOURNAL OF CANCER | 1992年 / 52卷 / 06期
关键词：
D O I：
10.1002/ijc.2910520607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The serum hyaluronan (HA) level of 238 women with breast cancer was measured by means of a specific radiometric assay. The results show no significant increase in serum HA when compared to levels in 120 control sera. A number of prognostic factors were evaluated including stage of disease, lymph-node involvement, tumour size, histology and presence of oestrogen and progesterone receptors in the tumour. No correlation was found with serum HA concentration and we conclude that serum HA level is of no prognostic significance in breast cancer.
引用
收藏
页码：873 / 876
页数：4
相关论文
共 50 条
  • [1] SERUM HYALURONAN (HYALURONIC-ACID) IN BREAST-CANCER PATIENTS
    DELPECH, B
    CHEVALLIER, B
    REINHARDT, N
    JULIEN, JP
    DUVAL, C
    MAINGONNAT, C
    BASTIT, P
    ASSELAIN, B
    INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (03) : 388 - 390
  • [2] SERUM IMMUNOGLOBULIN LEVELS IN PATIENTS WITH BREAST-CANCER
    ROBERTS, MM
    BATHGATE, EM
    STEVENSON, A
    CANCER, 1975, 36 (01) : 221 - 224
  • [3] SERUM FERRITIN LEVELS IN PATIENTS WITH BREAST-CANCER
    MARCUS, DM
    ZINBERG, N
    CLINICAL RESEARCH, 1975, 23 (03): : A447 - A447
  • [4] SERUM OSTEOCALCIN LEVELS IN BREAST-CANCER PATIENTS
    PIETSCHMANN, P
    ZIELINSKI, C
    WOLOSZCZUK, W
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (05) : 456 - 458
  • [5] THE PROGNOSTIC VALUE OF SERUM IGE LEVELS IN PRIMARY BREAST-CANCER
    OWNBY, D
    OWNBY, H
    ROI, L
    HOWARD, L
    BAKER, L
    HEPPNER, G
    BRENNAN, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 150 - 150
  • [6] PROGNOSTIC-SIGNIFICANCE OF SERUM PROLACTIN LEVELS IN ADVANCED BREAST-CANCER
    DOWSETT, M
    MCGARRICK, GE
    HARRIS, AL
    COOMBES, RC
    SMITH, IE
    JEFFCOATE, SL
    BRITISH JOURNAL OF CANCER, 1983, 47 (06) : 763 - 769
  • [7] PROGNOSTIC VALUE OF SERUM TETRANECTIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    HOGDALL, CK
    SOLETORMOS, G
    NIELSEN, D
    NORGAARDPEDERSEN, B
    DOMBERNOWSKY, P
    CLEMMENSEN, I
    ACTA ONCOLOGICA, 1993, 32 (06) : 631 - 636
  • [8] SERUM OSTEOCALCIN LEVELS IN PATIENTS WITH PRIMARY AND METASTATIC BREAST-CANCER
    GOERNER, R
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 793 - 796
  • [9] RHYTHMIC FLUCTUATIONS OF CEA SERUM LEVELS IN BREAST-CANCER PATIENTS
    JAGER, W
    DIEDRICH, M
    SAUERBREI, W
    WILDT, L
    ANTICANCER RESEARCH, 1987, 7 (04) : 711 - 715
  • [10] Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer
    Klotz, Daniel Martin
    Link, Theresa
    Wimberger, Pauline
    Kuhlmann, Jan Dominik
    MOLECULAR ONCOLOGY, 2021, 15 (12) : 3626 - 3638
12345